Skip to main content
OpenTrials
Completed

NCT Number: NCT07210372

Axial Stability in Short and Long Eyes After Cataract Surgery

Post operative intraocular lens position is being measured after cataract surgery in 34 patients with long and short eyes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kepler University Clinic, Linz

Linz, 4020, Austria

About this study

Prediction of the post-operative IOL position in long and short eyes the prediction difficult. Therefore, it is relevant to evaluate the post-operative IOL position in patients with an axial eye length outside the typical range. This study will help to improve the prediction of the post-operative refractive outcome in short and long eyes after implantation of a Clareon IOL. Therefore, three different OCT based measurements will be used (IOLMaster700, CZM; CASIA II, Tomey; SM-39, CSO), respectively. Post-operatively, these measurements will be repeated 1 hour, 1 week, and 12 weeks after surgery.

Hypothesis: Implantation of the Clareon IOL leads to a stable post-operative IOL position in short (≤22.75mm) and long (≥25.50mm) eyes.

Endpoints:

Primary Endpoint: change in anterior chamber depth (=IOL position) in mm from 1 week to 12 weeks post-operative visit for both short and long eyes (two separate analysis) (Refraction will be a secondary outcome due to its larger variability compared to ACD measurements 1)

Secondary Endpoint:

  • Refractive outcome after Clareon IOL implantation at 1- and 12-week visit o
  • Monocular BCDVA and DCIVA (66cm) at 1 week and 12-week post-operative visit

o Subjects with a post operative tilt (at 12-week post operative visit) ≥10⁰ will be excluded from VA analysis

  • Change in ACD in mm from 1 hour to 12 weeks, 1 hour to 1-week post-op visit for both short and long eyes Exploratory Endpoints
  • Comparison of refractive outcome between long and short eyes via prediction error for Barret Universal II for long eyes and Kane formula for short eyes with target emmetropia to -2.50D based on subject's visual needs ACD in mm 1 hour, 1 week, and 12 weeks post op as measured from corneal epithelium to anterior lens surface by IOL master 700, Casia II, and MS 39

Principal Objective: Aim of this study is to measure the change in the post-operative Anterior Chamber Depth of the Clareon monofocal IOL in short/long eyed patients at different post operative time points (1 hour, 1 week, and 12 weeks) during uneventful FLACS cataract surgery.

  • Exploratory/secondary Objectives:
  • To measure post-operative monocular corrected visual acuity of the Clareon IOL at distance and intermediate vision (66cm)
  • To Compare refractive outcomes between long and short eyes

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • bilateral cataract surger
  • axial eye length below 22,75mm or above 25.50mm

Exclusion criteria

  • ocular pathologies that could lead to an unstable capsular bag
  • pregnancy
  • preoperative visual acuity above 1.0logMar

Treatment and study plan

Primary outcomes

  1. change in anterior chamber depth

    Time frame: 1 week and 12 weeks post operative

    change in anterior chamber depth in millimeter

Secondary outcomes

  1. refractive outcome after intraocular lens implantation

    Time frame: 1 week and 12 weeks post operative

    spherical equivalent

Sponsors and collaborators

Lead sponsor

Johannes Kepler University of Linz

Other

Collaborators

  • Alcon Research

Registry information

Official study title

Post-Operative Axial Stabilty in Short and Long Eyes After Implanation of a Clareon Intraocular Lens

Acronym: ACDC

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Oct 7, 2025
Registry last updated
Oct 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.